BeyondSpring Inc.
BYSIHealthcare|Biotechnology|US
$0.63
-0.01 (-1.01%)
DCF Value
$0.18
Cash / Share
$0.16
Financials
Financial Snapshot
Market Cap
$25.7M
Enterprise Value
$23.2M
Revenue (TTM)
$0.00
Net Income (TTM)
-$6.7M
Cash & Investments
$6.5M
Net Cash
$6.4M
Free Cash Flow (TTM)
-$17.1M
Operating CF (TTM)
-$17.1M
Debt/Equity
-0.00
Cash Runway & Burn Rate
Cash on Hand
$6.5M
Quarterly Burn
$4.3M
Monthly Burn
$1.4M
Est. Runway
~1.5 quarters
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Investments | $11.7M | $30.6M | $3.9M | $35.9M | $109.5M | $72.4M | $37.3M | $15.3M | $2.9M | $12.6M | $6.5M | |
| Operating Cash Flow | -$13.7M | -$28.8M | -$40.0M | -$48.2M | -$43.7M | -$47.2M | -$28.2M | -$16.5M | -$16.4M | -$20.0M | -$17.1M | |
| Free Cash Flow | -$13.8M | -$28.9M | -$40.2M | -$48.2M | -$43.8M | -$50.1M | -$28.2M | -$16.6M | -$16.7M | -$20.1M | -$17.1M | |
| Capital Expenditure | -$64.0K | -$76.0K | -$207.0K | -$4.0K | -$52.0K | -$2.8M | -$34.0K | -$100.0K | -$224.0K | -$50.0K | -$543.00 | |
| Financing Cash Flow | $14.7M | $47.7M | $13.2M | $70.1M | $117.8M | $1.0K | $3.4M | $4.0K | $26.8M | $2.3M | -$2.2M |
R&D Spending
R&D (TTM)
$4.6M
R&D Intensity
—
R&D Growth vs Prior
+3.9%
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $180.0K | $1.4M | $1.4M | $0.00 | $0.00 | $0.00 | $0.00 | |
| R&D Expense | $10.4M | $88.9M | $51.6M | $31.3M | $41.8M | $36.9M | $25.6M | $7.3M | $2.6M | $4.4M | $4.6M | |
| R&D % of Revenue | — | — | — | — | 23218.3% | 2730.4% | 1893.6% | — | — | — | — | |
| SG&A | $1.9M | $9.1M | $5.9M | $8.9M | $22.6M | $30.7M | $13.0M | $7.5M | $6.1M | $4.6M | $3.8M |
Income Statement
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $180.0K | $1.4M | $1.4M | $0.00 | $0.00 | $0.00 | $0.00 | |
| Cost of Revenue | $18.0K | $32.0K | $48.0K | $77.0K | $0.00 | $0.00 | $0.00 | $302.0K | $0.00 | $87.0K | $38.0K | |
| Gross Profit | -$18.0K | -$32.0K | -$48.0K | -$77.0K | $180.0K | $1.4M | $1.4M | -$302.0K | $0.00 | -$87.0K | -$38.0K | |
| R&D | $10.4M | $88.9M | $51.6M | $31.3M | $41.8M | $36.9M | $25.6M | $7.3M | $2.6M | $4.4M | $4.6M | |
| SG&A | $1.9M | $9.1M | $5.9M | $8.9M | $22.6M | $30.7M | $13.0M | $7.5M | $6.1M | $4.6M | $3.8M | |
| Operating Income | -$12.4M | -$98.0M | -$57.5M | -$40.3M | -$64.2M | -$66.2M | -$37.2M | -$15.1M | -$8.8M | -$8.9M | -$8.3M | |
| Interest Expense | $177.0K | $0.00 | $0.00 | $206.0K | $85.0K | $87.0K | $17.0K | $0.00 | $0.00 | $0.00 | $0.00 | |
| Pretax Income | -$12.5M | -$96.4M | -$57.5M | -$40.3M | -$63.8M | -$64.6M | -$36.1M | -$13.9M | -$8.8M | -$8.6M | -$8.0M | |
| Net Income | -$12.0M | -$91.8M | -$54.9M | -$38.1M | -$61.0M | -$64.2M | -$33.3M | -$21.0M | -$11.1M | -$8.0M | -$6.7M | |
| EPS (Diluted) | -0.71 | -4.40 | -2.42 | -1.55 | -2.04 | -1.64 | -0.85 | -0.54 | -0.28 | -0.20 | -0.17 | |
| EBITDA | -$12.3M | -$97.9M | -$57.5M | -$40.0M | -$63.7M | -$64.5M | -$35.9M | -$13.6M | -$8.5M | -$8.5M | -$7.9M | |
| Shares Out. (M) | 16.88 | 20.87 | 22.67 | 24.65 | 29.98 | 39.02 | 39.09 | 39.00 | 39.73 | 40.41 | 41.12 |
Balance Sheet
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11.7M | $27.5M | $3.9M | $35.9M | $109.5M | $41.6M | $34.4M | $15.3M | $2.9M | $7.8M | $2.7M | |
| Short-Term Investments | $0.00 | $3.1M | $0.00 | $0.00 | $0.00 | $30.7M | $2.9M | $0.00 | $0.00 | $4.8M | $3.8M | |
| Total Current Assets | $14.7M | $32.3M | $5.9M | $40.9M | $113.4M | $75.1M | $38.5M | $18.4M | $28.6M | $20.9M | $9.9M | |
| Total Assets | $14.9M | $32.8M | $7.1M | $44.6M | $117.0M | $81.6M | $46.2M | $24.8M | $34.3M | $25.9M | $14.6M | |
| Total Current Liabilities | $2.6M | $4.8M | $16.4M | $10.1M | $13.8M | $15.2M | $7.4M | $8.0M | $11.0M | $13.6M | $14.2M | |
| Long-Term Debt | $0.00 | $0.00 | $0.00 | $1.4M | $2.2M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Total Liabilities | $2.6M | $4.8M | $16.4M | $13.4M | $25.2M | $60.7M | $49.2M | $48.3M | $48.6M | $49.9M | $50.6M | |
| Stockholders' Equity | $12.2M | $27.1M | -$7.8M | $30.3M | $88.3M | $26.7M | -$6.0M | -$26.8M | -$32.9M | -$32.2M | -$35.6M | |
| Retained Earnings | -$32.1M | -$123.9M | -$178.8M | -$216.8M | -$277.8M | -$342.0M | -$375.3M | -$396.3M | -$407.4M | -$408.4M | -$411.4M |
Cash Flow Statement
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$13.7M | -$28.8M | -$40.0M | -$48.2M | -$43.7M | -$47.2M | -$28.2M | -$16.5M | -$16.4M | -$20.0M | -$17.1M | |
| Capital Expenditure | -$64.0K | -$76.0K | -$207.0K | -$4.0K | -$52.0K | -$2.8M | -$34.0K | -$100.0K | -$224.0K | -$50.0K | -$543.00 | |
| Free Cash Flow | -$13.8M | -$28.9M | -$40.2M | -$48.2M | -$43.8M | -$50.1M | -$28.2M | -$16.6M | -$16.7M | -$20.1M | -$17.1M | |
| Investing Cash Flow | -$64.0K | -$3.1M | $2.9M | $10.1M | -$52.0K | -$20.4M | $18.2M | -$100.0K | -$12.0M | $13.5M | $1.3M | |
| Financing Cash Flow | $14.7M | $47.7M | $13.2M | $70.1M | $117.8M | $1.0K | $3.4M | $4.0K | $26.8M | $2.3M | -$2.2M | |
| Issuance of Stock | $15.3M | $50.5M | $14.0M | $68.6M | $112.6M | $39.0K | $0.00 | $0.00 | $0.00 | $2.0M | $2.0M | |
| Repurchase of Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Net Debt Issuance | $0.00 | $0.00 | $0.00 | $1.5M | $606.0K | $0.00 | -$1.6M | $0.00 | $3.9M | $286.0K | -$4.5M | |
| Stock Based Comp. | $0.00 | $22.7M | $6.6M | $0.00 | $8.2M | $3.2M | $1.7M | $554.0K | $2.1M | $0.00 | $0.00 | |
| Net Change in Cash | $866.0K | $15.8M | -$23.6M | $32.0M | $73.6M | -$67.9M | -$7.2M | -$16.6M | -$1.7M | $4.9M | -$6.8M |
Dilution Tracker
Shares outstanding grew 34.8% over 5 years — significant dilution
Shares Outstanding
41M
5-Year Share Growth
+34.8%
Stock Issuance (TTM)
$2.0M
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Out. (M) | 16.88 | 20.87 | 22.67 | 24.65 | 29.98 | 39.02 | 39.09 | 39.00 | 39.73 | 40.41 | 41.12 | |
| Change vs Prior % | — | 23.6% | 8.6% | 8.7% | 21.7% | 30.1% | 0.2% | -0.2% | 1.9% | 1.7% | 1.8% | |
| Stock Issuance | $15.3M | $50.5M | $14.0M | $68.6M | $112.6M | $39.0K | $0.00 | $0.00 | $0.00 | $2.0M | $2.0M | |
| Stock Repurchase | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Stock Based Comp. | $0.00 | $22.7M | $6.6M | $0.00 | $8.2M | $3.2M | $1.7M | $554.0K | $2.1M | $0.00 | $0.00 |
Margins & Profitability
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | — | — | — | — | 100.0% | 100.0% | 100.0% | — | — | — | — | |
| Operating Margin % | — | — | — | — | -35672.8% | -4903.0% | -2756.4% | — | — | — | — | |
| Net Margin % | — | — | — | — | -33873.9% | -4750.5% | -2463.3% | — | — | — | — | |
| EBITDA Margin % | — | — | — | — | -35366.1% | -4773.5% | -2654.9% | — | — | — | — | |
| FCF Margin % | — | — | — | — | -24331.7% | -3707.3% | -2086.2% | — | — | — | — | |
| ROE % | -98.8% | -338.9% | 706.5% | -125.8% | -69.0% | -240.5% | 556.6% | 78.4% | 33.8% | 24.8% | 20.0% | |
| ROA % | -80.6% | -279.5% | -776.9% | -85.5% | -52.1% | -78.6% | -72.0% | -84.8% | -32.4% | -30.8% | -45.8% | |
| ROIC % | -98.9% | -349.5% | 613.4% | -114.9% | -61.7% | -96.6% | -93.5% | -88.2% | -37.1% | -70.6% | -1429.6% | |
| R&D / Revenue % | — | — | — | — | 23218.3% | 2730.4% | 1893.6% | — | — | — | — |
Growth (Year over Year)
Fiscal years. Rising share count growth means dilution.
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 650.6% | 0.0% | -100.0% | 0.0% | 0.0% | |
| Gross Profit | -80.0% | -77.8% | -50.0% | -60.4% | 333.8% | 650.6% | 0.0% | -122.4% | 100.0% | 0.0% | |
| Operating Income | -65.5% | -692.2% | 41.3% | 30.0% | -59.3% | -3.2% | 43.8% | 59.5% | 42.0% | -2.2% | |
| Net Income | -50.7% | -664.1% | 40.2% | 30.6% | -60.1% | -5.3% | 48.1% | 36.8% | 47.1% | 28.1% | |
| EPS (Diluted) | -42.0% | -519.7% | 45.0% | 36.0% | -31.6% | 19.6% | 48.2% | 36.5% | 48.1% | 28.6% | |
| Operating Cash Flow | -108.5% | -110.2% | -38.8% | -20.5% | 9.2% | -8.0% | 40.4% | 41.5% | 0.2% | -21.8% | |
| Free Cash Flow | -108.2% | -109.8% | -39.1% | -19.9% | 9.1% | -14.4% | 43.7% | 41.2% | -0.6% | -20.4% | |
| R&D Expense | 66.1% | 752.0% | -42.0% | -39.3% | 33.3% | -11.7% | -30.6% | -71.6% | -63.6% | 66.0% | |
| SG&A Expense | 61.9% | 368.8% | -34.5% | 50.0% | 154.3% | 35.9% | -57.6% | -42.3% | -18.6% | -25.4% | |
| Total Assets | 35.9% | 120.2% | -78.5% | 530.8% | 162.7% | -30.2% | -43.4% | -46.3% | 38.3% | -24.4% | |
| Book Value / Share | 20.1% | 75.7% | -130.8% | 405.2% | 142.4% | -82.5% | -114.3% | -682.1% | 40.2% | -65.1% | |
| Debt | 0.0% | -100.0% | 0.0% | 0.0% | 9.6% | -17.1% | 38.8% | -82.9% | -30.5% | -45.7% | |
| Diluted Shares | 6.7% | 23.6% | 8.6% | 8.7% | 21.7% | 30.1% | 0.2% | -0.2% | 1.9% | 1.7% |
Valuation
P/E (TTM)At Loss
P/S0.00
10Y Low / Med / High54.40 / 130.85 / 2032.27
P/B-0.72
10Y Low / Med / High4.14 / 12.62 / 22.41
EV/EBITDAAt Loss
EV/Revenue0.00
10Y Low / Med / High32.61 / 102.68 / 1447.69
P/FCFAt Loss
Intrinsic Value Models (per share)
DCF Value
$0.18
Cash / Share
$0.16
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio | -22.40 | -6.61 | -7.75 | -10.00 | -5.98 | -2.76 | -2.21 | -1.67 | -5.82 | -8.15 | -3.79 | |
| P/S Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 2032.27 | 130.85 | 54.40 | 0.00 | 0.00 | 0.00 | 0.00 | |
| P/B Ratio | 22.24 | 22.41 | -54.72 | 12.62 | 4.14 | 6.62 | -12.29 | -1.31 | -1.97 | -2.05 | -0.72 | |
| EV/EBITDA | -20.95 | -5.91 | -7.32 | -8.74 | -4.09 | -2.15 | -1.23 | -1.51 | -7.36 | -6.84 | -2.95 | |
| EV/Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 1447.69 | 102.68 | 32.61 | 0.00 | 0.00 | 0.00 | 0.00 |
Analyst Estimates & Quality
Altman Z-Score
-41.30
Distress
Piotroski F-Score
1
Weak
Forward Estimates (consensus)
| Metric | FY2026 |
|---|---|
| Revenue | $194.6M |
| Net Income | $80.0M |
| EPS | $1.98 |
| # Analysts (EPS) | 1 |